Abstract
Matrix metalloproteinases (MMPs) degrade extracellular matrix components, and overexpression of these enzymes contributes to tissue destruction in arthritis. Of particular importance are the collagenases, MMP-1 and MMP-13, which have high activity against the interstitial collagens in cartilage. In this study, we address the mechanisms of two inhibitors of collagenase gene expression, the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and 15-deoxy-Δ(12,14)-prostaglandin J2 (15-dPGJ2). Although both inhibitors are ligands for the nuclear hormone receptor peroxisome proliferator-activated receptor-γ (PPAR-γ), a connection between PPAR-γ and collagenase gene expression has yet to be established. Here, we test the hypothesis that CDDO and 15-dPGJ2 use PPAR-γ to repress MMP gene expression. Our findings with the PPAR-γ antagonist 2-[4-[2-[3-(2,4-difluorophenyl)-1-heptylureido]ethyl]rsqb]-phenylsulfanyl]-2-methylpropionic acid (GW9662) and mouse embryonic fibroblasts lacking PPAR-γ demonstrate that CDDO and 15-dPGJ2 use PPAR-γ-independent mechanisms to inhibit collagenase gene expression. To address a potential PPAR-γ-independent mechanism leading to the repression of MMPs by CDDO, we tested the effect of CDDO on the transforming growth factor-β (TGF-β) signaling pathway. We found that CDDO requires Smads (transcription factors activated by TGF-β) for the repression of MMP-1. Specifically, MMP-1 is inhibited neither by CDDO in the absence of TGF-β receptor-activated Smad3 nor when a negative regulator, Smad7, attenuates TGF-β signaling. We conclude that CDDO represses MMP gene expression through a novel PPAR-γ-independent mechanism that requires Smad signaling.
- Received July 24, 2003.
- Accepted October 17, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|